Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2015

View Archived Issues

Reversible change in enzyme's substrate specificity accelerates elimination of toxic acetaldehyde

Recursion Pharmaceuticals wins NIH grant for rare disease drug discovery

Neos Therapeutics completes financing round to advance late-stage ADHD pipeline

Ipsen gains option to acquire Canbex Therapeutics

Roche and BioMed X collaborate on novel sensor technology platform

Amgen reports results from phase III trial comparing AMG-416 and cinacalcet in SHPT

Ampio reports results from phase II portion of STRUT study of Ampion in OA

FORMA Therapeutics achieves new objective under protein homeostasis collaboration with Celgene

Sareum provides update on its pipeline progress

Oncovirotherapy enhances tumor growth inhibition in PDAC model

NRC-AN-019, an Indian TKI for chronic myeloid leukemia patients

Potent antiviral activity seen with maturation inhibitor BMS-955176 in HIV-1-positive patients

Preclinical studies show LB-100 may be active against hematologic cancers

Bayer receives E.U. approval of Eylea for retinal vein occlusion

Xadago approved in Europe for mid-late stage Parkinson's disease

InSys Therapeutics' pharmaceutical cannabidiol receives FDA fast track designation

Shire completes acquisition of Meritage Pharma

Duke University patent describes LpxC inhibitors

Anacor patents LeuRS inhibitors for tuberculosis

Allergan prepares and tests S1P1 receptor ligands

Chinese researchers patent phenylacetic acid derivatives for cancer

Team in Shanghai reports identification of androgen receptor antagonists for prostate cancer

Biota Pharmaceuticals agrees to acquire Anaconda Pharma

FDA advisory committees recommend approval of Avedro's corneal cross-linking system

Boehringer Ingelheim places temporary clinical hold on BI-1181181

Actinogen starts phase I trial of Alzheimer's disease candidate

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...